Discover Digital Health at Neurodiem

Dr Ontaneda introduces Neurodiem’s Digital Health section, and reviews the impact of digital technologies on research and practice

Dr Daniel Ontaneda has reported the following commercial interests occurring within the past 12 months:
• Consultant/advisor: Genentech, Novartis, BMS, Biogen Idec
• Research grant: Genentech, Novartis